AR061835A1 - TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- AR061835A1 AR061835A1 ARP070103012A ARP070103012A AR061835A1 AR 061835 A1 AR061835 A1 AR 061835A1 AR P070103012 A ARP070103012 A AR P070103012A AR P070103012 A ARP070103012 A AR P070103012A AR 061835 A1 AR061835 A1 AR 061835A1
- Authority
- AR
- Argentina
- Prior art keywords
- branched
- linear
- group
- alkyl group
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Reivindicacion 1: Compuestos de formula (1) en la que: R1 representa un átomo de hidrogeno y R2 y R3 forman junto con los 2 átomos de carbono adyacentes a los que están unidos un ciclo de formula (2) en el que R6 representa un átomo de hidrogeno o de halogeno, o un grupo alquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, amino, alquilamino C1-6 lineal o ramificado, o dialquilamino C1-6 lineal o ramificado, X representa un átomo de oxígeno o un grupo N-OR7 en el que R7 representa un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado, arilo, o arilalquilo C1-6 lineal o ramificado, o R3 representa un átomo de hidrogeno y R1 y R2 forman junto con los 2 átomos de carbono adyacentes a los que están unidos un ciclo de formula (2) tal como se ha definido anteriormente, R4 y R5, idénticos o diferentes, representan un átomo de hidrogeno o de halogeno, o un grupo alquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, amino, alquilamino C1-6 lineal o ramificado, o dialquilamino C1-6 lineal o ramificado, A representa una cadena alquileno C1-6 en la que un grupo CH2 puede reemplazarse por un heteroátomo elegido entre oxígeno o azufre, o por un grupo NRa (en el que Ra representa un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado), B representa un grupo alquilo C1-6) lineal o ramificado, o alquenilo C2-6 lineal o ramificado, estando sustituidos estos grupos con un grupo de formula (3) en la que R8 representa un grupo - COOR y R9 representa un grupo -OR' en el que R y R', idénticos o diferentes, representan cada uno un átomo de hidrogeno, o un grupo alquilo C1-6 lineal o ramificado no sustituido o sustituido con uno o varios átomos de halogeno, entendiéndose que: la oxima =N-OR7 puede tener configuracion Z o E, por arilo se entiende un grupo fenilo, naftilo o bifenilo, pudiendo estar estos grupos parcialmente hidrogenados, por heteroarilo se entiende cualquier grupo aromático mono o bicíclico que contiene 5 a 10 eslabones, pudiendo estar parcialmente hidrogenado en uno de los ciclos en el caso de los heteroarilos bicíclicos, y que contiene 1 a 3 heteroátomos elegidos entre oxigeno, nitrogeno y azufre, pudiendo estar sustituidos los grupos arilo y heteroarilo así definidos con 1 a 3 grupos elegidos entre alquilo C1-6 lineal o ramificado, polihalogenoalquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, hidroxi carboxi, formilo, NRbRc (en el que Rb, y Rc, idénticos o diferentes, representan un átomo de hidrogeno, un grupo alquilo C1-6 lineal o ramificado, arilo o heteroarilo), éster, amido, nitro, ciano, o átomos de halogeno, sus enantiomeros y diastereoisomeros así como sus sales de adicion a un ácido o a una base farmacéuticamente aceptables.Claim 1: Compounds of formula (1) in which: R1 represents a hydrogen atom and R2 and R3 together with the 2 adjacent carbon atoms to which a cycle of formula (2) is attached in which R6 represents a hydrogen or halogen atom, or a linear or branched C1-6 alkyl group, linear or branched C1-6 alkoxy, amino, linear or branched C1-6 alkylamino, or linear or branched C1-6 dialkylamino, X represents an atom of oxygen or an N-OR7 group in which R7 represents a hydrogen atom or a linear or branched C1-6 alkyl, aryl, or linear or branched C1-6 arylalkyl group, or R3 represents a hydrogen atom and R1 and R2 form together with the 2 adjacent carbon atoms to which a cycle of formula (2) is attached as defined above, R4 and R5, identical or different, represent a hydrogen or halogen atom, or a C1- alkyl group 6 linear or branched, C1-6 linear or branched alkoxy, amino, C1-6 alkylamino line al or branched, or linear or branched C1-6 dialkylamino, A represents a C1-6 alkylene chain in which a CH2 group can be replaced by a heteroatom chosen from oxygen or sulfur, or by a NRa group (in which Ra represents a hydrogen atom or a linear or branched C1-6 alkyl group, B represents a linear or branched C1-6 alkyl group, or linear or branched C2-6 alkenyl, these groups being substituted with a group of formula (3) in which R8 represents a group - COOR and R9 represents a group -OR 'in which R and R', identical or different, each represent a hydrogen atom, or a linear or branched C1-6 alkyl group unsubstituted or substituted with one or several halogen atoms, it being understood that: the oxime = N-OR7 may have Z or E configuration, by aryl a phenyl, naphthyl or biphenyl group is understood, these groups being partially hydrogenated, heteroaryl is any aromatic group mono or bicyclic containing 5 at 10 links, being able to be partially hydrogenated in one of the cycles in the case of bicyclic heteroaryls, and containing 1 to 3 heteroatoms chosen from oxygen, nitrogen and sulfur, being able to substitute the aryl and heteroaryl groups thus defined with 1 to 3 groups chosen from linear or branched C1-6 alkyl, linear or branched C1-6 polyhalogenoalkyl, linear or branched C1-6 alkoxy, carboxy hydroxy, formyl, NRbRc (in which Rb, and Rc, identical or different, represent an atom of hydrogen, a linear or branched C1-6 alkyl group, aryl or heteroaryl), ester, amido, nitro, cyano, or halogen atoms, their enantiomers and diastereoisomers as well as their pharmaceutically acceptable acid or base addition salts.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0606247A FR2903404B1 (en) | 2006-07-10 | 2006-07-10 | NOVEL TETRACYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
Publications (1)
Publication Number | Publication Date |
---|---|
AR061835A1 true AR061835A1 (en) | 2008-09-24 |
Family
ID=37722239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070103012A AR061835A1 (en) | 2006-07-10 | 2007-07-06 | TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR061835A1 (en) |
FR (1) | FR2903404B1 (en) |
WO (1) | WO2008006969A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
WO2011107494A1 (en) | 2010-03-03 | 2011-09-09 | Sanofi | Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof |
DE102010015123A1 (en) | 2010-04-16 | 2011-10-20 | Sanofi-Aventis Deutschland Gmbh | New benzylamidic diphenylazetidinone compounds, useful for treating lipid disorders, hyperlipidemia, atherosclerotic manifestations or insulin resistance, and for reducing serum cholesterol levels |
EP2582709B1 (en) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013068486A1 (en) | 2011-11-08 | 2013-05-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the diagnosis and treatment of male infertility |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2804431A1 (en) * | 2000-02-02 | 2001-08-03 | Adir | NEW HETEROCYCLIC DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR2858321B1 (en) * | 2003-07-28 | 2006-01-20 | Servier Lab | NOVEL HETEROCYCLIC OXIMIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
-
2006
- 2006-07-10 FR FR0606247A patent/FR2903404B1/en not_active Expired - Fee Related
-
2007
- 2007-07-06 AR ARP070103012A patent/AR061835A1/en unknown
- 2007-07-09 WO PCT/FR2007/001174 patent/WO2008006969A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008006969A2 (en) | 2008-01-17 |
FR2903404A1 (en) | 2008-01-11 |
FR2903404B1 (en) | 2008-08-22 |
WO2008006969A3 (en) | 2008-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR061835A1 (en) | TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR063988A1 (en) | HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR061739A1 (en) | NEW NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR062677A1 (en) | DERIVATIVES OF BIARIL-SULFONAMIDE, PRODUCTION PROCESSES AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM | |
AR013494A1 (en) | DERIVATIVES OF CARBOXAMIDOTIAZOLES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
AR089774A1 (en) | DERIVATIVES OF INDOLIZINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
NI201000022A (en) | NEW 6-TRIAZOLOPYRIDACINE-SULFANIL BENZOTHIAZOLE AND BENZHIMIDAZOLE DERIVATIVES, THEIR PREPARATION PROCEDURE, THEIR APPLICATION AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND NEW USE MAINLY AS MET INHIBITORS. | |
AR075892A1 (en) | DERIVATIVES OF BENZOTIADIAZEPINAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR033379A1 (en) | DIFENILUREA COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR061377A1 (en) | DIAZENIODIOLATE DERIVATIVES, PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN CARDIOVASCULAR PATHOLOGIES. | |
AR069643A1 (en) | DIAZENIDIOLATE DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
CU20100157A7 (en) | NEW DIHYDROINDOLONE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR054121A1 (en) | PHENYL PIRIDYL PIPERAZINE COMPOUNDS, PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PHARMACOLOGICAL USES AS ANTAGONIST OF HISTAMINERGIC RECEPTORS H3 | |
GT200700084A (en) | DERIVATIVES OF INDANIL-PIPERAZINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
AR041883A1 (en) | PIRIDOPIRIMIDINONE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR052663A1 (en) | HETEROCICLIC OXYM COMPOUNDS, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR045125A1 (en) | HETEROCICLIC OXYM COMPOUNDS, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR072103A1 (en) | DERIVATIVES OF (PIPERAZINILO WITH BRIDGE LINKS) -1- ALCANONA, ITS USE AS P75 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR054120A1 (en) | PHENYL PIRIDYL PIPERAZINE COMPOUNDS, PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PHARMACOLOGICAL USES AS ANTAGONIST OF HISTAMINERGIC RECEPTORS H3 | |
AR052802A1 (en) | BENZOTIAZINE AND BENZOTIADIAZINE COMPOUNDS A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR072486A1 (en) | CYCLE-RENTED BENZOTIADIAZINE DERIVATIVES THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR050542A1 (en) | IMIDAZOPIRIDINE COMPOUNDS PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR044672A1 (en) | BENZOTIAZINE AND BENZOTIADIAZINE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR077492A1 (en) | USEFUL CHROMENIC DERIVATIVES FOR THE TREATMENT OF PSYCHIATRIC AND NEUROLOGICAL DISEASES, PROCEDURE TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM. | |
AR041758A1 (en) | COMPOUNDS OF 2,3-DIHIDRO-4 (1H) -PIRIDONE, PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |